Skip to main content
logo
Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.3061
+0.0062 (2.07%)
At close: Jul 31, 2026, 4:00 PM EDT
0.3039
-0.0022 (-0.72%)
After-hours: Jul 31, 2026, 8:00 PM EDT

Kairos Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
71521---
Market Cap Growth
-58.62%-29.20%----
Enterprise Value
2.8810.2919.61000
Last Close Price
0.310.711.52---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.232.334.37---
P/TBV Ratio
1.152.083.79---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-00-0.31-0.49-0.33
Debt / FCF Ratio
---7.88--
Net Debt / Equity Ratio
-0.69-0.71-0.27-0.26-0.12-0.26
Net Debt / EBITDA Ratio
0.630.830.58-0.35-0.35-0.17
Net Debt / FCF Ratio
0.981.310.326.73-0.41-0.74
Quick Ratio
8.5322.571.280.040.270.04
Current Ratio
10.3127.074.200.040.270.04
Return on Equity (ROE)
-100.21%-97.99%-192.96%111.27%89.51%284.14%
Return on Assets (ROA)
-97.62%-90.54%-69.60%-171.31%-63.06%-492.33%
Return on Invested Capital (ROIC)
-343.81%-208.14%-107.28%-234.31%-67.94%-343.29%
Return on Capital Employed (ROCE)
-102.90%-100.24%-140.47%168.29%64.74%257.38%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-55.40%-62.27%-9.38%-1.42%-11.86%-63.55%
Total Shareholder Return
-55.40%-62.27%-9.38%-1.42%-11.86%-63.55%
SEC Filings: 10-K · 10-Q